BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 27591236)

  • 1. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial.
    Lemmers M; Verschoor MA; Oude Rengerink K; Naaktgeboren C; Opmeer BC; Bossuyt PM; Huirne JA; Janssen CA; Radder C; Klinkert ER; Langenveld J; Catshoek R; Van der Voet L; Siemens F; Geomini P; Van Hooff MH; Van der Ploeg JM; Coppus SF; Ankum WM; Mol BW;
    Hum Reprod; 2016 Nov; 31(11):2421-2427. PubMed ID: 27591236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Hentzen JEKR; Verschoor MA; Lemmers M; Ankum WM; Mol BWJ; van Wely M
    Hum Reprod; 2017 Aug; 32(8):1674-1683. PubMed ID: 28575402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MisoREST: Surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: A cohort study.
    Lemmers M; Verschoor MAC; Oude Rengerink K; Naaktgeboren C; Bossuyt PM; Huirne JAF; Janssen IAH; Radder C; Klinkert ER; Langenveld J; van der Voet L; Siemens FF; Bongers MY; van Hooff MH; van der Ploeg M; Sjors FPJ; Coppus SFPJ; Ankum WM; Mol BWJ;
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():83-89. PubMed ID: 28209537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility and obstetric outcomes after curettage versus expectant management in randomised and non-randomised women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage.
    Lemmers M; Verschoor MAC; Overwater K; Bossuyt PM; Hendriks D; Hemelaar M; Schutte JM; Adriaanse AH; Ankum WM; Huirne JAF; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():78-82. PubMed ID: 28199872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.
    Verschoor MA; Lemmers M; Bossuyt PM; Graziosi GC; Hajenius PJ; Hendriks DJ; van Hooff MA; van Meurs HS; Opmeer BC; van Tulder MW; Bouwma L; Catshoek R; Geomini P; Klinkert ER; Langenveld J; Nieboer TE; van der Ploeg JM; Radder CM; Spinder T; van der Voet LF; Mol BW; Huirne JA; Ankum WM
    BMC Pregnancy Childbirth; 2013 May; 13():102. PubMed ID: 23638956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial.
    Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis.
    Sotiriadis A; Makrydimas G; Papatheodorou S; Ioannidis JP
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1104-13. PubMed ID: 15863551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).
    van den Berg J; Hamel CC; Snijders MP; Coppus SF; Vandenbussche FP
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):443. PubMed ID: 31775677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of misoprostol for early pregnancy failure.
    Tang OS; Ho PC
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):581-6. PubMed ID: 17099326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for managing miscarriage: a network meta-analysis.
    Ghosh J; Papadopoulou A; Devall AJ; Jeffery HC; Beeson LE; Do V; Price MJ; Tobias A; Tunçalp Ö; Lavelanet A; Gülmezoglu AM; Coomarasamy A; Gallos ID
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD012602. PubMed ID: 34061352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage.
    Sahin HG; Sahin HA; Kocer M
    Eur J Contracept Reprod Health Care; 2001 Sep; 6(3):141-4. PubMed ID: 11763977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage.
    Bagratee JS; Khullar V; Regan L; Moodley J; Kagoro H
    Hum Reprod; 2004 Feb; 19(2):266-71. PubMed ID: 14747165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single versus repeat doses of misoprostol for treatment of early pregnancy loss-a randomized clinical trial.
    Mizrachi Y; Dekalo A; Gluck O; Miremberg H; Dafna L; Feldstein O; Weiner E; Bar J; Sagiv R
    Hum Reprod; 2017 Jun; 32(6):1202-1207. PubMed ID: 28402415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage.
    Shelley JM; Healy D; Grover S
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):122-7. PubMed ID: 15760312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial.
    Kong GW; Lok IH; Yiu AK; Hui AS; Lai BP; Chung TK
    Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):170-7. PubMed ID: 23488984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
    Chung T; Leung P; Cheung LP; Haines C; Chang AM
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of early pregnancy loss.
    Graziosi GC; Mol BW; Ankum WM; Bruinse HW
    Int J Gynaecol Obstet; 2004 Sep; 86(3):337-46. PubMed ID: 15325850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison.
    van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ
    Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misoprostol versus manual vacuum aspiration for treatment of first-trimester incomplete miscarriage in a low-resource setting: A randomized controlled trial.
    Nwafor JI; Agwu UM; Egbuji CC; Ekwedigwe KC
    Niger J Clin Pract; 2020 May; 23(5):638-646. PubMed ID: 32367870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.